Category: CannabisNewsWire Release

420 with CNW — Marijuana Department in California Gives Universities $20M to Study Cannabis

The California Department of Cannabis Control (DCC) revealed that on April 26, 2023, it had given 16 educational institutions funding totaling $19,942,918 for marijuana research. The funds will support projects researching how marijuana affects young people’s psychological wellness, innovative cannabinoids such as Delta-8 and Delta-10 THC, and a groundbreaking study of California’s historic cannabis genetics.

The DCC expects these activities will set the standard for marijuana research and enhance scientific study to better comprehend cannabis’ advantages and drawbacks.

Six divisions of colleges received awards, with Cal Poly Humboldt receiving the largest award of $2,699,178 for its grassroots study on heritage cannabis genetics. Additionally, $2 million each were given to the universities of California, Los Angeles, and Irvine to research the potency of marijuana. The first double-blind, federally acceptable, placebo-controlled drug administration trial comparing the consequences of inhaled marijuana plants to inhaled extracts will also be carried out through a partnership involving UC Irvine and UCLA.

The awards were given out based on their capacity to produce fundamental research that will underpin expanding future knowledge, their capability to enhance the public’s comprehension of marijuana, their potential to deliver information beneficial for legislation, and their solid scientific approach. Sixteen concepts were selected from a list of 98 total submissions.

The DCC also unveiled a brand-new funding initiative in February, promising $20 million to boost and develop the state’s marijuana business. The retail access grant program aims to promote legal retail businesses in locations where existing customers do not have easy access to legally grown marijuana.

Last year, the department executed 155 warrants for search operations, an increase from 61 in 2021, based on the report issued by the DCC at the beginning of March. The DCC captured an estimated 41,726 pounds of marijuana in 2021, with a market value of almost $78 million. In 2022, the amount rose to 144,254 pounds, with a value of more than $243 million.

In general, the DCC’s funding program aims to increase security for customers, foster an equitable market and increase the availability of California’s retail marijuana market. The DCC is eager to share the findings after the research is finished since the awards will offer insightful information on issues that concern Californian’s consumers, businesses, and legislators.

The program is designed to provide funding for research projects that address gaps in knowledge and understanding of the marijuana industry. It is hoped that this will lead to better regulation and policymaking in the future.

These studies funded by the DCC in California will add to the work being done by companies such as IGC Pharma Inc. (NYSE American: IGC), which lean more toward conducting research with the aim of commercializing marijuana-derived FDA-approved formulations.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Marijuana Startups Leverage AI to Keep Competitive

The dawn of AI is here, with more and more sectors adopting the use of this technology to improve efficiency, optimize the growth process of businesses, and assist in making faster and more informed decisions. The cannabis industry has not been left behind, with more companies adopting this technology.

For instance, Green Rush Consulting recently launched a chatbot that specifically caters to the needs of the cannabis industry. For more than a decade, this consulting firm helped marijuana entrepreneurs acquire licenses using human consultants.

Zeta Ceti gained inspiration from ChatGPT, leading to the development of Oddysee AI, which can do about 70% of the work on marijuana licensing. Ceti, who showcased the product at a cannabis conference in Manhattan recently, revealed that the remaining 30% would be done by humans.

Jason Rosenberg, cofounder of Oddysee AI, explained how the product would direct users to a cannabis brand by names in their search. Oddysee AI is only one among many other startups in marijuana AI. A Toronto-based company, Predictmedix, is developing a program to test for marijuana impairment.

Little Dragon, a delivery-only business that specializes in high-THC products, also recently launched an AI program on an equity crowdfunding platform. Rachel Figueras, the cofounder of Little Dragon Dabs, revealed that its AI could learn a user’s preferences and assist them in choosing products better than a person would.

While it is expected that more players in the industry will follow suit as the adoption of AI grows, the results will vary due to the difference in regulations in states that have legalized some form of marijuana.  Additionally, the increased adoption of this technology in the industry may put licensing consultants, budtenders and other participants out of business.

There are upsides to the technology’s use, however, including the issues it could solve, such as impaired driving. Predictmedix revealed that it utilized multispectral cameras to conduct an analysis of physiological data patterns and identify impairment, regardless of whether that impairment was induced by marijuana, alcohol or even mental illness.

In a statement, Dr. Rahul Kushwah, COO of Predictmedix, added that impairment testing by AI could be stepped up to accommodate higher numbers, which would in turn increase its usefulness for mass-testing scenarios such as workplace screenings and roadside checkpoints. Standardized labeling and testing is also another issue AI can solve, as highlighted by ChatGPT.  However, more scientific data and studies are needed on the effects of marijuana in order to make these tools more effective.

As artificial intelligence tools help customers make better product choices, the market could become more sophisticated as buyers become drawn to products made from plants that show evidence of superior genetics, better cultivation methods (organic vs. plants grown using synthetic agrochemicals, for example). This attention to the way cannabis is grown may create extra demand for modern cultivation equipment from the likes of Advanced Container Technologies Inc. (OTC: ACTX) as growers seek to harvest superior yields.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Alternative Products Expo Slated to Return to Medellín for Upcoming Two-Day Event

The Alternative Products Expo, produced by ZJ Events, is being held this year for two days in Medellín, Colombia. Slated for May 20–21, 2023, the conference will feature an estimated 200 companies exhibiting more than 1,000 products in the alternative products space. Medellín, which hosted the expo in 2017 as well, offers an ideal location for the conference, which is designed to provide attendees with key information from the alternative-products space as well as invaluable networking opportunities. The event has become the largest expo series for all things vape, hemp and counterculture, and is a key gathering for smoke-shop owners, independent retailers, buyers, vendors and counterculture enthusiasts. The expo agenda includes presentations from key players in the field as well as access to new releases and high-quality products including vape, delta 8, hemp, CBD, disposables, kratom, mushrooms, functional beverages, nootropics, dietary supplements and much more. “Returning to beautiful Medellín is always very special for us at Alt Pro Expo,” said Alternative Products Expo brand manager Cesar Jimenez in the press release. “This is an incredibly diverse city and is home to some of the most incredible developments in the alternatives space. We have been very fortunate to channel these incredible resources and showcase a wide array of products and services to thousands of consumers and would-be consumers. We have always received wonderful support from the visiting crowds who have been key to making previous editions of Alt Pro Expo Medellín a resounding success. Our carefully designed environment offers excellent opportunities for relationship-building where attendees can educate themselves deeply about the sector, pick the brains of the finest industry experts and even explore potential synergies with numerous partners throughout the value chain. We encourage everyone from established industry professionals, avid customers, passionate community members and curious watchers to come and be a part of this unique conference.”

To view the full press release, visit https://cnw.fm/ote7X

About Alternative Products Expo

Alternative Products Expo, formerly USA CBD Expo, is a production of ZJ Events. Event founders were once exhibitors who, after attending countless trade show events, saw an opportunity to build upon their experience and create an event that combined the best they had seen with their own notion of what was missing in these business gatherings. By bringing the alternative community together, we seek to provide industry professionals from all corners of the market with an immersive and unique opportunity for networking and business expansion.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Twitter Makes Additional Concessions on Marijuana Advertising in US

Twitter has further relaxed its restrictions on marijuana advertising, allowing verified, state-legal companies to include packaged marijuana goods in their marketing campaigns and permitting ads in additional U.S. markets. According to a blog post by Alexa Alianiello, Twitter’s head of partnerships and sales, certified marijuana advertisers are now allowed to responsibly link to their websites and online stores that sell THC, CBD and marijuana-related goods and services.

Alianiello also stated that the platform has made changes for those with medical licenses and offered up more markets for recreational use, but there are some restrictions. Twitter’s publicly available drug ad policy does not state which new recreational and medical markets are now accessible to cannabis advertisements. However, the social media site is now allowing medical marijuana ads that target users in Florida, Alabama, Minnesota, Arkansas, Mississippi, Oklahoma, Missouri, Pennsylvania, Rhode Island, Puerto Rico, West Virginia and South Dakota, according to Mattio Communications CEO Rosie Mattio. The new adult-use cannabis market in Missouri will also be able to run cannabis ads.

In Mattio’s opinion, Twitter’s decision to allow images of packaged marijuana products allows these brands more potential to connect with consumers and inform them about the real product rather than just using the platform as a brand-recognition type of move. The privately owned social media site gave the nod to American marijuana advertising in February, a decision that was applauded by a lot of marijuana shareholders.

At the start, however, cannabis businesses reported conflicting outcomes when they attempted to market their products on Twitter. Lisa Buffo, CEO and founder of the Marijuana Marketing Association, says that she has witnessed all kinds of companies — big and small — attempt advertising with Twitter. Some have been approved, others have not, and others have had mixed results in the process. She goes on to say that advertising results vary and that a campaign’s and a brand’s success depends on how well they fit the platform.

In the blog post outlining the modifications to the ad policy, Alianiello stated that the company had received valuable input from the marijuana sector, which it had taken into account to expand opportunities. Twitter also accepts, subject to its restrictions, cannabis adverts directed at users in Thailand and Canada.

Other online platforms, including Alphabet, Google’s parent company, as well as Instagram, Facebook, and WhatsApp platforms run by Meta, generally forbid the promotion of marijuana products. However, Google does make an exception for some ads promoting CBD and hemp.

For entities such as IGC Pharma Inc. (NYSE American: IGC), whose focus is on developing FDA-approved treatments from cannabis, the rules on advertising marijuana set by Twitter and other such platforms are of little interest because there is a clear set of federal regulations governing how approved medicines can or cannot be advertised.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Florida Activists Close to Meeting Signature Goal to Qualify Marijuana Legalization Bill for Ballot

Cannabis advocates in the state of Florida have gathered 841,130 signatures for a ballot initiative to legalize cannabis. A poll published recently shows that 70% of residents in the state favor the idea of approving a constitutional amendment to enact marijuana legalization. Data released by the Florida Division of Elections estimates that the legalization campaign may soon reach the 891,523 signature mandate by the end of May.

Earlier this year, advocates had collected enough signatures to commence a state review by the Supreme Court regarding the text of the measure.  By February’s end, the campaign had already surpassed 420,000 signatures with this figure rising to 635,961 by the end of March.

The state’s Supreme Court will focus on ensuring that the language of the legislation doesn’t mislead voters or violate the constitution’s single-subject rule. If the court rules that the measure meets the set standards, then the legalization campaign will only be required to submit enough signatures to qualify for the ballot.

Previous attempts to place adult-use legalization resolutions on the ballot have been rejected and/or challenged by the court, which opined that the text of proposed initiatives were misleading.

The state of Florida approved a medical marijuana constitutional amendment in 2016.

Smart&Safe Florida, the organization that filed the marijuana legislation last summer, is being sponsored almost entirely by Trulieve, the largest medical cannabis operator in Florida. Trulieve granted seed money that helped get the campaign going and is said to have contributed roughly $25 million to these efforts.

The bill’s approval will allow existing medical marijuana companies in the state to start selling cannabis to all individuals aged 21 years of age and older. It also contains a provision that would permit legislators to approve additional businesses that are not licensed marijuana dispensaries. Individuals aged 21 and older would be allowed to buy and possess no more than an ounce of marijuana, only 5g of which could be cannabis concentrate products.

However, the resolution excludes provisions such as relief for individuals with previous marijuana convictions and expungements. It should be noted that home growing by consumers would also not be permitted. The bill would take effect six months after it was approved by voters in Florida.

Meanwhile, advocates who aren’t directly involved in the campaign revealed in 2022 that they were looking into plans to have voters decide on what would be a complementary resolution that would allow adults to cultivate their own marijuana at home.

Opening up home cultivation of marijuana by adults would open up exciting opportunities for out-of-state enterprises such as Advanced Container Technologies Inc. (OTC: ACTX) that focus on making indoor cultivation equipment for high-value crops including cannabis.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Dosing Completed on Human Clinical Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has completed dosing for 36 subjects in its human clinical oral nicotine study: NIC-H22-1. According to the announcement, the study is the result of the focus Lexaria has had for years on oral nicotine formulations as an alternative to vaping or smoking; the company noted that results from the study could lead to more rapid commercial adoption and distribution of its patented DehydraTECH(TM) absorption technology, which is designed to improve oral uptake. Statistics show that some 7 million people die every year from cigarette smoking, and alternatives for nicotine delivery are desperately needed. Lexaria’s DehydraTECH-nicotine is already patent granted for oral nicotine delivery in Australia and pending in numerous other countries. The company noted that its DehydraTECH-powered purified nicotine white pouch formulation contains no tobacco, and studies show that its DehydraTECH-nicotine can be 10 to 20 times fast and deliver up to tenfold higher levels of nicotine into blood plasma from oral absorption than concentration-matched controls. LEXX’s NIC-H22-1 study is a human pharmacokinetic randomized, double-blinded, cross-over study with a minimum of 36 human volunteers who currently smoke cigarettes. The study objectives include determining the quantity of nicotine in blood at various time points and collecting vital-sign data, such as blood pressure, heart rate and respiratory rate; Lexaria will provide further updates and any relevant material findings as they become available.

To view the full press release, visit https://cnw.fm/OnTm3

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 28 patents granted and many patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com. 

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

The Third Annual NECANN Illinois Cannabis Convention – The Only B2B Convention in Illinois

NECANN, a pioneer in developing engaging conventions for the cannabis industry, is proud to announce its third edition of The Illinois Cannabis Convention being held on June 2-3rd, 2023. This year’s event will build on the success of the 2022 Illinois Cannabis Convention, with scaled-up operations that will see even more exhibitors, presenters, products, and even attendees in what promises to be the best B2B cannabis convention in Illinois.

The event will be held at the Schaumburg Convention Center in Chicago from 10 AM to 3 PM. It will play host to cannabis enthusiasts, farmers, entrepreneurs, and investors, with discussion topics ranging from careers in cannabis to marijuana investment opportunities and challenges. Some of the presenters at this two-day event will include Rebecca Abraham, the Founder and President of Acute on Chronic; Nadav Aschner, a partner at The Roadman Law Group; Bennett Cawthon, the President of Streamline Farms; and Jennifer Clark, a Strategy and Operations Consultant at LaunchSpot Consulting.

NECANN has been developing conventions for the cannabis industry since 2014, offering an avenue for expanding market opportunities for entrepreneurs, investors, businesses, patients, educators, cannabis advocates, and consumers. Throughout the years, the company has refined its approach to conventions, adapting to the current state and potential of each local market it has ventured into thus far. In addition, its collaborative approach with the local industries and communities has helped set its conventions apart, stamping its place as the go-to cannabis convention in the United States.

The third annual Illinois Cannabis Convention draws from the learnings from NECANN’s previous events, promising an avenue where exhibitors can achieve consistently high returns, attendees can learn a lot, and the local cannabis market can grow. This is an event that understands the booming cannabis space, especially in Chicago. As such, it looks to tap into that growth and the buzz around cannabis to draw interested parties together in one place to exchange value, ideas, products, and knowledge on how to push the industry forward.

To learn more, please visit https://cnw.fm/EVW4N

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

The 2023 Alternative Products Expo – Everything Counterculture Under One Roof

ZJ Events is proud to announce the 2023 Alternative Products Expo, the ultimate gathering for smoke shop owners, independent retailers, buyers, and counterculture enthusiasts. This event looks to build on the success and momentum of previous events dating back to 2019, which have achieved massive success and offered incredible value and exposure to attendees.

The Alternative Products Expo offers an avenue for anyone in the counterculture industry to connect with top manufacturers, explore the latest trends and innovations, and take advantage of exclusive show discounts in a fun and exciting atmosphere. Termed the largest vape, hemp, and counterculture expo, this event offers a unique and exciting experience with opportunities for everyone at the event. Such opportunities will range from bulk buying, experiencing the business’ fun side, enjoying specials and free samples, and having a sneak peek into new industry releases.

This upcoming event, held in Medellín, Colombia, will feature partners such as The Hemp Doctor, Cannavist, Mellow Fellow, Cannabis & Tech Today, and 3Chi. In addition, featured products will include disposables, nootropics, dietary supplements, Delta8, Vapes, CBD, and mushrooms, among others, making it the go-to event for a wide variety of niche industry players looking to find mainstream distribution and traditional marketing opportunities for their products.

ZJ Events has, since its inception, sought to address the public demand for better business gatherings that are different from the traditionally dull and ordinary conventions. This has birthed various shows including, but not limited to, the flagship Alternative Products Expo, Expo Verse, Biz Cann Expo, Inno Venture, Vape South America, and the USA CBD Expo. In addition to Medellín Colombia, the Alternative Products Expo will also take place in Dallas on July 13-15, 2023, and in Vegas on September 14-16, 2023, all with the same underlying theme of having everything counterculture under one roof.

To learn more, please visit https://cnw.fm/nopVp and https://cnw.fm/WsNmI

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Four New Patents Added to the Company’s Growing Patent Portfolio

  • Lexaria has received notifications of four new patents either awarded or allowed
  • After the awarding of these patents, Lexaria’s total patent portfolio will have grown to 32 granted patents worldwide
  • The new granted patent in Japan is under Patent Family #3: Stable Ready-to-Drink Beverage Compositions Comprising Lipophilic Active Agents
  • The new granted Australian patent is under Patent Family #18: Compositions and Methods for Enhanced Delivery of Antiviral Agents
  • The new allowed Canadian patent is under Patent Family #8: Compositions Infused with Nicotine Compounds and Methods of Use Thereof
  • The new allowed US patent is under Patent Family #21: Compositions and Methods for Treating Hypertension and is the first patent in the Patent Family

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms and the global leader in enhancing the speed and efficiency of orally-delivered fat-soluble active molecules and drugs through its patented DehydraTECH(TM) technology – has announced that the company has received notification of four newly awarded or allowed patents (https://cnw.fm/EDyAd). The new patents will add to Lexaria’s growing portfolio, bringing the total number of patents granted worldwide to 32, with several more pending.

Lexaria’s newly awarded or allowed patents include the following:

  • Japan: Lexaria’s new patent in Japan is under Patent Family #3: Stable Ready-to-Drink Beverage Compositions Comprising Lipophilic Active Agents. This patent is the fifth awarded in Japan, strengthening the company’s growing Japanese patent portfolio. Under this particular patent family, Lexaria has existing patents in Australia, India, Japan, and Mexico.
  • Australia: Lexaria’s new Australian patent is categorized under Patent Family #18: Compositions and Methods for Enhanced Delivery of Antiviral Agents. The new patent brings Lexaria’s total in Australia to ten and is the second patent in this Patent Family, following a similar patent in the United States awarded in 2022.
  • Canada: Lexaria’s Canadian patent under Patent Family #8: Compositions Infused with Nicotine Compounds and Methods of Use Thereof has been allowed. This will be Lexaria’s second patent in this Patent Family and follows a similar issuance in Australia in 2022.
  • United States: Lexaria has been notified that a new patent under Patent Family #21: Compositions and Methods for Treating Hypertension has been allowed in the US. The company believes this patent could provide significant importance in its pursuit of utilizing DehydraTECH-CBD concerning its expected upcoming FDA Investigational New Drug application. The outcomes of a series of hypertension studies already completed were instrumental in achieving this particular patent and is the first patent in the Patent Family.

When a patent is “allowed,” it means that the patent office has notified the company that it has been determined that they will soon grant the patent, often subject to some administrative tasks and/or fees.

Lexaria’s DehydraTECH technology speeds up delivery, increases bioavailability, increases brain absorption, improves drug potency, reduces drug administration cost, and masks unwanted taste. The company has conducted animal studies that demonstrated a propensity for DehydraTECH to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,700 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Two markets of penetration for Lexaria include cardiovascular drugs and CBD. The global cardiovascular drug market is expected to reach $173.48 billion by 2026 (https://cnw.fm/HTuz0). The global CBD market is expected to reach $111.8 billion by 2030 (https://cnw.fm/CJlRS). Lexaria’s DehydraTECH technology anticipates leveraging both markets and others, including oral nicotine, PDE5 inhibitors, and more avenues in which Lexaria has filed for patent protection for.

The new patents will allow Lexaria to continue its research and use of DehydraTECH for several indications. The patents offer protection on the company’s technology and allow it to explore further additional opportunities for use – reducing drug administration costs, enhancing efficacy, and more.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Marijuana Emerges as a Major Issue in Thailand Upcoming Elections

The Bhumjaithai Party, a Thai political movement credited with helping to partially legalize cannabis, has accused opponents of using the issue for political gain ahead of the country’s May 14 election, claiming that cannabis reform is a must if it is to join any governing coalition.

Thailand changed its marijuana laws in June 2022, allowing licensed companies to grow and sell the substance solely for medical purposes. However, parliament failed to adopt a comprehensive marijuana act before it was disbanded in March to make room for election campaigning.

Recreational smoking has flourished in the legal void, prompting worry among critics who argue the legislation is too broad and too fast. The main prodemocracy parties, Move Forward and Pheu Thai, both of which are anticipated to win the majority of seats, claim that the liberalization of marijuana has been chaotic, encouraged marijuana usage and has fallen short of helping impoverished farmers as promised due to the high costs of investment.

The issue has also divided a generally conservative populace in a nation with tight drug laws, and many are concerned by the easy access to high-strength marijuana, especially among young people.

In response to the criticism, Supachai Jaisamutr, the Bhumjaithai party’s top marijuana official, cautioned that politics is masking the contribution of cannabis to Thailand’s economy, which is expected to reach at least $1.2 billion by 2025.

Thais are expected to vote in leaders for the 500 seats in the lower house on May 14, 2023. A 250-member Senate that was appointed by Prime Minister Prayuth Chan-ocha and his backers, however, plays a controversial role in the election. The Senate is expected to back the conservative party that wins the elections. Furthermore, it holds one-third of the total 750 votes for the prime minister after the government is formed.

The main conflict is considered one between conservative parties, particularly Prayuth’s United Thai Nation, which wants to retake power, and prodemocracy parties, which have been out of power since Prayuth’s coup in 2014. However, the marijuana controversy is playing a surprisingly significant role. Experts predict between 80 and 100 seats could be won by Bhumjaithai, the second-largest party, which is led by Health Minister Anutin Charnvirakul. The party would potentially have the final say in whether a government-forming coalition would be made up of prodemocracy forces or the conservative group.

Long-time supporters of marijuana decriminalization have been appalled by the politics of marijuana. They worry that the political commotion surrounding cannabis may result in restrictive regulations when the next administration debates the specifics of the Marijuana Act.

For small Thai cannabis businesses, the political conflict has overshadowed the biggest issue facing the domestic market: the illicit importation of marijuana from the United States or Laos, which is five times cheaper than Thai produce.

Marijuana is a divisive topic in many parts of the world, not just in Thailand, and enterprises such as IGC Pharma Inc. (NYSE American: IGC) that have opted to come up with pharmaceutical-grade medicines from this plant somehow avoid the controversy surrounding the plant since their work involves adhering to the strict drug-development laws in the jurisdictions where they intend to get their medicines approved for use in the healthcare system.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.